Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
QS127: Obesity in adults: quality standard
10.1038/cddis.2017.28 Summary Keywords GLP-1, oral delivery, vagal afferents, diabetes, obesity, peptide Citation New RRC, Bogus M, Travers GN, Hahn U, Vaiceliunaite A, Burnet M, Wang JH and Wen H (2024) Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery
Q: Is bariatric surgery safer than GLP-1 medications
Osteoarthritis Cartilage 2003;11:783-9
Strengths and limitations This cohort study was performed using data from Danish nationwide registries
US$ 25.92
US$ 23.26
US$ 25.91
US$ 24.17
US$ 26.40
US$ 28.66
US$ 20.42
US$ 22.29
US$ 20.71
US$ 28.73
US$ 29.42
